Avalyn Pharma Inc. Common Stock

AVLN

AVLNAvalyn Pharma Inc. Common Stock US flag

NASDAQ Global Market

28.30

USD

+2.62

- -

1.25BMarket Cap

Income Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -
+ Sales & Services Revenue	- -	- -
- Cost of Revenue	- -	- -
+ Cost of Goods & Services	- -	- -
Gross Profit	- -	- -
+ Other Operating Income	- -	- -
- Operating Expenses	57	91
+ Selling, General & Admin	11	15
+ Research & Development	46	77
+ Other Operating Expense	- -	- -
Operating Income (Loss)	-57	-91
- Non-Operating (Income) Loss	-7	-6
+ Interest Expense, Net	-7	-6
+ Interest Expense	- -	- -
- Interest Income	7	6
+ Other Non-Op (Income) Loss	- -	- -
Pretax Income	-50	-85
- Income Tax Expense (Benefit)	- -	- -
- (Income) Loss from Affiliates	- -	- -
Income (Loss) from Cont Ops	-50	-85
- Net Extraordinary Losses (Gains)	- -	- -
+ Discontinued Operations	- -	- -
+ Extraord. & Accounting Changes	- -	- -
Income (Loss) Incl. MI	-50	-85
- Minority Interest	- -	- -
Net Income, GAAP	-50	-85
- Preferred Dividends	- -	- -
- Other Adjustments	- -	- -
Net Income Avail to Common, GAAP	-50	-85
EBIT	-57	-91
EBITDA	-57	-91
EBITDA Margin (%)	- -	- -
EBITA	-57	-91
Gross Margin (%)	- -	- -
Operating Margin (%)	- -	- -
Profit Margin (%)	- -	- -
Sales per Employee	- -	- -
Dividend per Share	- -	- -
Depreciation Expense	- -	- -
Basic Weighted Avg Shares	42	42
Basic EPS, GAAP	-1.19	-2.04
Basic EPS from Cont Ops	-1.19	-2.04
Diluted Weighted Avg Shares	42	42
Diluted EPS, GAAP	-1.19	-2.04
Diluted EPS from Cont Ops	-1.19	-2.04

Balance Sheet (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

Total Current Assets	114	144
+ Cash, Cash Equivalents & STI	111	138
+ Cash & Cash Equivalents	24	52
+ ST Investments	87	86
+ Accounts & Notes Receiv	1	1
+ Accounts Receivable, Net	- -	- -
+ Notes Receivable, Net	- -	- -
+ Loans Receivable, Net	- -	- -
+ Other Receivable, Net	1	1
+ Inventories	- -	- -
+ Raw Materials	- -	- -
+ Work In Process	- -	- -
+ Finished Goods	- -	- -
+ Inventory Adjustments	- -	- -
+ Other Inventory	- -	- -
+ Other ST Assets	3	5
+ Misc ST Assets	- -	- -
+ Prepaid Expenses	- -	- -
+ ST Derivative & Hedging Assets	- -	- -
+ ST Assets Held-for-Sale	- -	- -
+ ST Deferred Tax Assets	- -	- -
Total Noncurrent Assets	10	5
+ Property, Plant & Equip, Net	- -	2
+ Property, Plant & Equip	- -	2
- Accumulated Depreciation	- -	- -
+ LT Investments & Receivables	7	- -
+ LT Investments	7	- -
+ LT Receivables	- -	- -
+ Other LT Assets	3	3
+ Total Intangible Assets	- -	- -
+ Goodwill	- -	- -
+ Other Intangible Assets	- -	- -
+ LT Deferred Tax Assets	- -	- -
+ LT Derivative & Hedging Assets	- -	- -
+ Misc LT Assets	3	3
Total Assets	125	149
+ Payables & Accruals	6	9
+ Accounts Payable	2	4
+ Accrued Taxes	- -	- -
+ Interest & Dividends Payable	- -	- -
+ Other Payables & Accruals	4	6
+ ST Debt	- -	- -
+ ST Borrowings	- -	- -
+ ST Finance Leases	- -	- -
+ Other ST Liabilities	3	4
+ Deferred Revenue	- -	- -
+ Derivatives & Hedging	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Misc ST Liabilities	3	4
Total Current Liabilities	9	14
+ LT Debt	- -	1
+ LT Borrowings	- -	- -
+ LT Finance Leases	- -	1
+ Other LT Liabilities	290	372
+ Accrued Liabilities	- -	- -
+ Pension Liabilities	- -	- -
+ Deferred Revenue	- -	- -
+ Deferred Tax Liabilities	- -	- -
+ Derivatives & Hedging	- -	- -
+ Misc LT Liabilities	290	372
Total Noncurrent Liabilities	290	373
Total Liabilities	299	388
+ Preferred Equity and Hybrid Capital	- -	- -
+ Share Capital & APIC	5	27
+ Common Stock	- -	- -
+ Additional Paid in Capital	5	27
- Treasury Stock	- -	- -
+ Retained Earnings	-180	-265
+ Other Equity	- -	- -
Equity Before Minority Interest	-175	-239
+ Minority/Non Controlling Interest	- -	- -
Total Equity	-175	-239
Total Liabilities & Equity	125	149
Shares Outstanding	42	42
Number of Employees	- -	- -
Capital Leases - Total	- -	2
Net Debt	-24	-52
Net Debt to Equity	13.73	21.92
Tangible Common Equity Ratio	-140.16	-160.3
Current Ratio	13.08	10.19
Cash Conversion Cycle	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2024 Y	2025 Y
As of date	12/31/2024	12/31/2025

+ Net Income	-50	-85
+ Depreciation & Amortization	- -	- -
+ Non-Cash Items	- -	1
+ Stock-Based Compensation	2	3
+ Deferred Income Taxes	- -	- -
+ Asset Impairment Charge	- -	- -
+ Other Non-Cash Adj	-2	-2
+ Chg in Non-Cash Work Cap	1	3
+ (Inc) Dec in Accts Receiv	- -	- -
+ (Inc) Dec in Inventories	- -	- -
+ (Inc) Dec in Prepaid Assets	3	-1
+ Inc (Dec) in Accts Payable	4	4
+ Inc (Dec) in Other	-6	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Operating Activities	-48	-81
+ Change in Fixed & Intang	- -	- -
+ Disp in Fixed & Intang	- -	- -
+ Disp of Fixed Prod Assets	- -	- -
+ Disp of Intangible Assets	- -	- -
+ Acq of Fixed & Intang	- -	- -
+ Acq of Fixed Prod Assets	- -	- -
+ Acq of Intangible Assets	- -	- -
+ Cash (Repurchase) of Equity	- -	- -
+ Increase in Capital Stock	- -	- -
+ Decrease in Capital Stock	- -	- -
+ Net Change in LT Investment	-91	10
+ Dec in LT Investment	40	120
+ Inc in LT Investment	-131	-109
+ Net Cash From Acq & Div	- -	- -
+ Cash from Divestitures	- -	- -
+ Cash for Acq of Subs	- -	- -
+ Cash for JVs	- -	- -
+ Other Investing Activities	- -	- -
+ Net Cash From Disc Ops	- -	- -
Cash from Investing Activities	-91	10
+ Dividends Paid	- -	- -
+ Net Cash From Debt	- -	- -
+ Cash From Debt	- -	- -
+ Repayments of Debt	- -	- -
+ Other Financing Activities	- -	100
+ Net Cash From Disc Ops	- -	- -
Cash from Financing Activities	- -	100
Effect of Foreign Exchange Rates	- -	- -
Net Changes in Cash	-140	28
EBITDA	-57	-91
EBITDA Margin (%)	- -	- -
Free Cash Flow	-48	-82
Net Cash Paid for Acquisitions	- -	- -
Free Cash Flow to Firm	- -	- -
Free Cash Flow to Equity	- -	-82
Free Cash Flow per Basic Share	-1.16	-1.96
Price/Free Cash Flow	- -	- -
Cash Flow to Net Income	0.97	0.96
Capital Expenditures	- -	- -